Timing anti-PD-L1 checkpoint blockade immunotherapy to enhance tumor irradiation
Seung Young Lee, Joanna Pagacz, Sera Averbek, David Scholten, Yue Liu, Stephen J. Kron
This study shows that timing anti-PD-L1 therapy after radiation enhances tumor response by preventing CTL depletion and improving PD-L1 blockade.
Cancers · Jan 24, 2025Peer-reviewedCancer Biology